InvestorsHub Logo
Followers 38
Posts 2912
Boards Moderated 0
Alias Born 06/05/2012

Re: Lemoncat post# 378972

Saturday, 10/16/2021 7:15:31 PM

Saturday, October 16, 2021 7:15:31 PM

Post# of 403033
I’d rather have 50% of the next 10 or 15 years. I don’t see how you could license just for Covid. Licensing would more likely be for IV administered Brilacidin. That would cover every bacteria Brilacidin will treat as well as every virus; including the next pandemic. I’m not thinking about just this version of Covid. We have a lot more than just the answer to the current pandemic and I hope that Leo does not rush a deal based on this version of Covid.

Lemoncat said,

The goal would be to maximize sales while COVID is still a thing. If it took six months to a year to really get operations up to speed that could be $10B lost (REGN antibody revenues for the year). Better to lock in that $5B share and then IPIX does whatever it wants with every indication in the pipeline.

COVID probably won't be around forever.
2022: $10B market
2023: $2B market

I'd rather have 50% of both year rather than 100% of the second.


"It is difficult to get a man to understand something, when his salary depends upon his not understanding it."

Upton Sinclair

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News